ZEPATIER 50 mg/100 mg, film-coated tablet 28 tablets
Active ingredients: Elbasvir, Grazoprevir, Grazoprevir monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZEPATIER 50 mg/100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) aluminium de 7 comprimé(s)
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66198173CIP73006170CIP133400930061701Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ELBASVIRcomprimé | 50 mg · un comprimé | SA |
| GRAZOPRÉVIRcomprimé | 100 mg · un comprimé | FT |
| GRAZOPRÉVIR MONOHYDRATÉcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.